Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

NCT00396383 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient cell mobilization for tandem transplants

Conditions

Multiple Myeloma

Interventions

DRUG: plerixafor

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]